RHY 4.11% 7.0¢ rhythm biosciences limited

Ann: RHY Signs first ColoSTAT site for Clinical Trial - Study 7, page-7

  1. 987 Posts.
    lightbulb Created with Sketch. 302
    Agree BUT difficult technology and very long way to go.i hope it doesn’t overshoot before we get further down the path . Could be disappointments along the way. Prefer patient investors to accumulate on weakness 
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.